Cognivia CEO Dominique Demolle, PhD, Named Among 2022’s Most Inspiring People by PharmaVoice
We are pleased to share that our very own Dominique Demolle, CEO, has been recognized as one of…
We are pleased to share that our very own Dominique Demolle, CEO, has been recognized as one of…
Drug development has changed significantly throughout the past 2 decades – including great leaps forward in areas from…
New research suggests that a high percentage of reported side effects from COVID-19 vaccines may be due to what’s…
The overall risk of clinical trial failure is still too high – meaning more repeat trials, lost timelines…
Covariates are typically used to control for factors that may impact the measurement of outcomes, particularly to describe individual patient characteristics that may or may not relate to treatment response. In fact, all patient baseline characteristics collected are potential covariates linked with the patient’s outcome.
Mont-Saint-Guibert, Belgium, (Jan. 5, 2022 /PRNewswire) – Cognivia today announced a new name for the company formerly known as Tools4Patient,…